Optical Imaging Market - 2022

November 2025 | 243 pages | ID: OF3927F66431EN
DataM Intelligence

Abstracts

The Optical Imaging Market was valued at US$ 1.6 billion in 2022 and is anticipated to reach by , at a CAGR of 0.124 from 2026 to 2032.

The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Optical Imaging Market.

This report delivers a comprehensive overview of the Optical Imaging Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Optical Imaging Market. The Optical Imaging Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2022–.

Optical Imaging Market Scope:

By Technology

• Optical Coherence Tomography (OCT)
• Endoscopy
• Photoacoustic imaging
• Diffused optical tomography (DOT)
• Raman Spectroscopy
• Others

By Product

• Imaging System
• Illumination System
• Software
• Lenses
• Camera

By Therapeutic Area

• Ophthalmology
• Oncology
• Neurology
• Cardiology
• Dermatology
• Others

By Application

• Pathological Imaging
• Intra-Operative Imaging
• Others

By End User

• Hospitals/Clinics
• Diagnostic Imaging Centres
• Research Laboratories
• Others

Key Players

• Abbott Laboratories
• Carl-Zeiss AG
• Canon Inc.
• Danaher Corporation
• Koninklijke Philips N.V.
• PerkinElmer Inc.
• Topcon Healthcare
• Leica Microsystems
• Visionix
• Cylite Pty Ltd

Major Highlights

This report delivers a comprehensive overview of the Optical Imaging Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Optical Imaging Market. The Optical Imaging Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2022–.

This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Regional Analysis:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Partner Identification

• Increase Your Customer Base by 3X using our Partner Identification tool
• Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
• Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
• Prioritize partners by strategic fit rather than general capability.

Why Choose DataM?

• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.

Target Audience 2026

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Contents

1. METHODOLOGY AND SCOPE

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. DEFINITION AND OVERVIEW

3. EXECUTIVE SUMMARY

3.1. Snippet by Technology
3.2. Snippet by Product
3.3. Snippet by Therapeutic Area
3.4. Snippet by Application
3.5. Snippet by End User
3.6. Snippet by Region

4. DYNAMICS

4.1. Impacting Factors
  4.1.1. Drivers
    4.1.1.1. Novel Product Launches and Research Studies
    4.1.1.2. An Increase In The Prevalence Of Eye Disorders
  4.1.2. Restraints
    4.1.2.1. Reimbursements Challenges
  4.1.3. Opportunity
    4.1.3.1. Emerging Economics
  4.1.4. Impact Analysis

5. INDUSTRY ANALYSIS

5.1. Porter’s 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. COVID-19 ANALYSIS

6.1. Analysis of COVID-19
  6.1.1. Scenario Before COVID-19
  6.1.2. Scenario During COVID-19
  6.1.3. Scenario Post Covid-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. BY TECHNOLOGY

7.1. Introduction
  7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  7.1.2. Market Attractiveness Index, By Technology
7.2. Optical Coherence Tomography (OCT)*
  7.2.1. Introduction
  7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Endoscopy
7.4. Photoacoustic imaging
7.5. Diffused optical tomography (DOT)
7.6. Raman Spectroscopy
7.7. Others

8. BY PRODUCT

8.1. Introduction
  8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  8.1.2. Market Attractiveness Index, By Product
8.2. Imaging System *
  8.2.1. Introduction
  8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Illumination System
8.4. Software
8.5. Lenses
8.6. Camera

9. BY THERAPEUTIC AREA

9.1. Introduction
  9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapeutic Area
  9.1.2. Market Attractiveness Index, By Therapeutic Area
9.2. Ophthalmology *
  9.2.1. Introduction
  9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Oncology
9.4. Neurology
9.5. Cardiology
9.6. Dermatology
9.7. Others

10. BY APPLICATION

10.1. Introduction
  10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  10.1.2. Market Attractiveness Index, By Application
10.2. Pathological Imaging *
  10.2.1. Introduction
  10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Intra-Operative Imaging
10.4. Others

11. BY END USER

11.1. Introduction
  11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  11.1.2. Market Attractiveness Index, By End User
11.2. Hospitals/Clinics *
  11.2.1. Introduction
  11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Diagnostic Imaging Centres
11.4. Research Laboratories
11.5. Others

12. BY REGION

12.1. Introduction
  12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  12.1.2. Market Attractiveness Index, By Region
12.2. North America
  12.2.1. Introduction
  12.2.2. Key Region-Specific Dynamics
  12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapeutic Area
  12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    12.2.8.1. U.S.
    12.2.8.2. Canada
    12.2.8.3. Mexico
12.3. Europe
  12.3.1. Introduction
  12.3.2. Key Region-Specific Dynamics
  12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapeutic Area
  12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    12.3.8.1. Germany
    12.3.8.2. U.K.
    12.3.8.3. France
    12.3.8.4. Spain
    12.3.8.5. Italy
    12.3.8.6. Rest of Europe
12.4. South America
  12.4.1. Introduction
  12.4.2. Key Region-Specific Dynamics
  12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapeutic Area
  12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    12.4.8.1. Brazil
    12.4.8.2. Argentina
    12.4.8.3. Rest of South America
12.5. Asia-Pacific
  12.5.1. Introduction
  12.5.2. Key Region-Specific Dynamics
  12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapeutic Area
  12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    12.5.8.1. China
    12.5.8.2. India
    12.5.8.3. Japan
    12.5.8.4. Australia
    12.5.8.5. Rest of Asia-Pacific
12.6. Middle East and Africa
  12.6.1. Introduction
  12.6.2. Key Region-Specific Dynamics
  12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapeutic Area
  12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

13. COMPETITIVE LANDSCAPE

13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis

14. COMPANY PROFILES

14.1. Abbott Laboratories*
  14.1.1. Company Overview
  14.1.2. Product Portfolio and Description
  14.1.3. Financial Overview
  14.1.4. Key Developments
14.2. Carl-Zeiss AG
14.3. Canon Inc.
14.4. Danaher Corporation
14.5. Koninklijke Philips N.V.
14.6. PerkinElmer Inc.
14.7. Topcon Healthcare
14.8. Leica Microsystems
14.9. Visionix
14.10. Cylite Pty Ltd (*LIST NOT EXHAUSTIVE)

15. APPENDIX

15.1. About Us and Services
15.2. Contact Us